The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

P.A. Mukhortova

Center for Expertise and Quality Control of Medical Care

T.O. Bessonova

Center for Expertise and Quality Control of Medical Care;
Penza Institute for Postgraduate Medical Education

R.A. Teryan

Center for Expertise and Quality Control of Medical Care

O.S. Shemyakova

Center for Expertise and Quality Control of Medical Care

K.I. Matrenin

Center for Expertise and Quality Control of Medical Care

A.D. Bagdasarov

Center for Expertise and Quality Control of Medical Care;
St. Petersburg Chemical Pharmaceutical University

N.Z. Musina

St. Petersburg Chemical Pharmaceutical University

Economic evaluation of PCSK9 inhibitors inclusion in the list of medicines for outpatient preferential drug provision («23 INNs» list) for secondary prevention of cardiovascular events

Authors:

P.A. Mukhortova, T.O. Bessonova, R.A. Teryan, O.S. Shemyakova, K.I. Matrenin, A.D. Bagdasarov, N.Z. Musina

More about the authors

Views: 1243

Downloaded: 85


To cite this article:

Mukhortova PA, Bessonova TO, Teryan RA, Shemyakova OS, Matrenin KI, Bagdasarov AD, Musina NZ. Economic evaluation of PCSK9 inhibitors inclusion in the list of medicines for outpatient preferential drug provision («23 INNs» list) for secondary prevention of cardiovascular events. Medical Technologies. Assessment and Choice. 2022;(4):51‑62. (In Russ.)
https://doi.org/10.17116/medtech20224404151

Recommended articles:
MicroRNA-34a in cardiovascular disease: a glimpse into the future. Russian Cardiology Bulletin. 2023;(1):14-22
Imme­diate resu­lts of intrathoracic inno­minate artery reco­nstructions. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2023;(2):217-222
Hybrid inte­rventions for athe­rosclerotic lesions of the lower limb arte­ries. Piro­gov Russian Journal of Surgery = Khirurgiya. Zurnal im. N.I. Piro­gova. 2023;(9):103-109

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.